MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.rmed.2021.106638

Медицинская библиотека · Respiratory medicine · 2021

ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.

Ferrer Santos, Sancho Jesús, Bocigas Irene, Bures Enric, Mora Heidi, Monclou Erik, Mulet Alba, Quezada Antonio, Royo Pablo, Signes-Costa Jaime

СтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

High-Flow Nasal Cannula (HFNC) therapy is useful treatment in patients with acute respiratory failure (ARF). The ROX index (ratio of pulse oximetry/fraction of inspired oxygen to respiratory rate) has been evaluated to predict success of HFNC in patients with pneumonia.

OBJECTIVE

The aim of this study was to determine whether the ROX Index could predict HFNC therapy success in patients with ARF due to SARS-CoV-2 pneumonia.

METHODS

An observational, prospective study was performed including patients admitted with ARF secondary to SARS-CoV-2 pneumonia who met criteria for HFNC therapy initiation. Demographic, radiological, laboratory and clinical course data were collected. The ROX index was calculated at 1 h, 6 h, 12 h and 24 h after starting HFNC.

RESULTS

In total 85 patients were included (age, 64.51 + 11.78 years; male, 69.4%). HFNC failed in 47 (55.3%) patients, of whom 45 (97.8%) were initially managed with noninvasive ventilation (NIV). ROX index at 24 h was the best predictor of HFNC success (AUC 0.826, 95%CI 0.593-1.00, p = 0.015) with a cut-off point of 5.35 (S 0.91, Sp 0.79, PPV 0.92, NPP 0.79). In multivariate logistic regression analysis ROX index at 24 h proved the best predictor of HFNC success.

CONCLUSIONS

ROX index at 24 h with a cut-off point of 5.35 predicts HFNC success in patients with SARS-Cov-2-induced ARF.

Для цитирования: Ferrer Santos, Sancho Jesús, Bocigas Irene, Bures Enric, Mora Heidi, Monclou Erik, Mulet Alba, Quezada Antonio, Royo Pablo, Signes-Costa Jaime. ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.. Respiratory medicine. 2021. DOI: 10.1016/j.rmed.2021.106638.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.